Bintai Kinden Corporation Berhad Emerges as Substantial Shareholder in Malaysian Genomics Resource Centre Berhad
Feb 17, 2022 14:00 HKT |  |
|
Therapeutic Goods Administration of Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years)
Feb 17, 2022 10:45 HKT |  |
|
EC Healthcare Acquires Multi-Disciplinary Medical Services Centers
Feb 16, 2022 20:50 HKT |  |
|
Malaysian Genomics Resource Centre Berhad Records Significant Increase in Revenue of RM7.63 Million
Feb 16, 2022 15:00 HKT | |
|
Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries
Feb 16, 2022 07:00 HKT | |
|
EC Healthcare Opens New Healthcare Medical Centre, Further Consolidate the Leading Position and Expand Market Share
Feb 14, 2022 08:50 HKT | |
|
Lepu Biopharma Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange
Feb 10, 2022 09:50 HKT |  |
|
Novotech Recognized as Top 10 CRO in CenterWatch Global Site Relationship Benchmarking Report
Feb 09, 2022 15:00 HKT |  |
|
Oculis appoints Dr. Bastian Dehmel as Chief Development Officer
Feb 08, 2022 15:10 HKT |  |
|
SinoMab Announces IND APPLICATION FOR SN1011 ACCEPTED BY NMPA CDE
Feb 07, 2022 18:05 HKT |  |
|
IgY antibody technology against SARS-CoV-2 unveiled
Jan 28, 2022 18:08 HKT | |
|
EuroEyes Acquires 100% Issued Shares in London Vision Clinic Partners Limited
Jan 28, 2022 15:55 HKT |  |
|
Labnovation's COVID-19 ART Test Kit, Imported by Clearbridge, one of two COVID-19 ART Test Kits approved by Philippines FDA for Self-Testing
Jan 26, 2022 20:45 HKT |  |
|
HMI Group Strengthens Specialist Offering, Acquires Majority Stake in Eagle Eye Centre
Jan 24, 2022 11:00 HKT |  |
|
Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022
Jan 18, 2022 13:00 HKT |  |
|
Senior Management Increases Shareholdings in EC Healthcare With Strong Confidence in the Group's Future Development
Jan 17, 2022 20:18 HKT | |
|
Arcensus has appointed Prof. Dr. Arndt Rolfs as New CEO
Jan 12, 2022 15:00 HKT |  |
|
Phase I Clinical Trial of AIM mRNA COVID-19 Vaccine (LVRNA009) Won the Praise of the Industry for High Safety and Well Tolerance
Jan 12, 2022 10:26 HKT | |
|
SinoMab Awarded the "Best Small and Mid-Cap Company" and "Best CEO" in the Selection of the "6th Hong Kong Golden Stocks Awards" and the "Listed Company with the Most Growth Potential" in the Selection of "2021 Sina Finance Golden Unicorn Best Hong Kong and US Listed Companies"
Jan 11, 2022 16:55 HKT | |
|
Clinical Evaluation of LeSoleil Against COVID-19
Jan 11, 2022 12:00 HKT |  |
|